0001981285-26-000001.txt : 20260320 0001981285-26-000001.hdr.sgml : 20260320 20260320135320 ACCESSION NUMBER: 0001981285-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260320 DATE AS OF CHANGE: 20260320 EFFECTIVENESS DATE: 20260320 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Consano Bio, Inc. CENTRAL INDEX KEY: 0001981285 ORGANIZATION NAME: EIN: 920833225 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-577172 FILM NUMBER: 26777591 BUSINESS ADDRESS: STREET 1: 100 SUMMIT DRIVE CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: 617-798-4559 MAIL ADDRESS: STREET 1: 100 SUMMIT DRIVE CITY: BURLINGTON STATE: MA ZIP: 01803 FORMER COMPANY: FORMER CONFORMED NAME: CONSANO BIOLOGICS, LLC DATE OF NAME CHANGE: 20230613 D 1 primary_doc.xml X0708 D LIVE 0001981285 Consano Bio, Inc. 100 SUMMIT DRIVE BURLINGTON MA MASSACHUSETTS 01803 617-798-4559 DELAWARE CONSANO BIOLOGICS, LLC Corporation true 2024 Andrew Hall 100 Summit Drive Burlington MA MASSACHUSETTS 01803 Executive Officer Director Chief Executive Officer and Secretary of Issuer Jennifer Schmitke 100 Summit Drive Burlington MA MASSACHUSETTS 01803 Executive Officer President and Chief Operating Officer of Issuer Doug Vander Weide 100 Summit Drive Burlington MA MASSACHUSETTS 01803 Director Christopher Centeno 100 Summit Drive Burlington MA MASSACHUSETTS 01803 Director Bill Abbington 100 Summit Drive Burlington MA MASSACHUSETTS 01803 Director Jerome Adams 100 Summit Drive Burlington MA MASSACHUSETTS 01803 Director Michael Pede 100 Summit Drive Burlington MA MASSACHUSETTS 01803 Director Joe Schiesl 100 Summit Drive Burlington MA MASSACHUSETTS 01803 Director John Conway 100 Summit Drive Burlington MA MASSACHUSETTS 01803 Director Biotechnology Decline to Disclose 06b false 2026-03-06 false true false 0 48858795 34824466 14034329 false 28 0 0 0 false Consano Bio, Inc. /s/Andrew Hall Andrew Hall Chief Executive Officer of Issuer 2026-03-20